U.S. and European Clinical Development for Asian MedTech Startups

On-demand webinar

Uncategorized
Published on:
May 6, 2022

This webinar is part of the free webinar series “Expanding Beyond APAC” launched to discuss the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies.  

The webinar series is prepared together with APACMed, Asia Pacific’s regional trade association which represents manufacturers and providers of medical equipment and devices, in-vitro diagnostics, digital health; as well as local associations and other key stakeholders within the medical technology industry. 

The webinar “U.S. and European Clinical Development for Asian MedTech Startups” focused on key considerations for Asian MedTech companies interested in engaging in clinical trials in these geographies. The webinar examined the clinical trial landscape in each region, including patient pathways, interactions with clinical trial sites, and key metrics related to startup timelines, trial execution timelines, and other key dates. We additionally discussed key items for consideration, including clinical trial budgets, accurate timelines, and risk mitigation strategies, including the lingering effects of COVID-19 on the clinical trial area in these geographies.

WHO SHOULD JOIN THIS WEBINAR:

MedTech, digital health and IVD startups, and Small & Medium-sized Enterprises based in the Asia Pacific planning to expand commercially to Europe and North America. 

WHAT YOU CAN LEARN:
  • What is the site startup/ethics committee process for clinical trials in these geographies
  • How to estimate trial timelines and costs for clinical trials in these geographies
  • How sponsors can interact with site Principal Investigators and study teams, including the role of CROs
  • Risk mitigation strategies and factors for clinical trials in these geographies

Meet the speakers

Chris Rao – Senior Vice President, Clinical Development, Alira Health

Christopher has 15 years of experience in clinical research, with a focus on clinical trial design and operations. As a strategist, Christopher works identifies client’s key needs early and creates tailored, targeted plans for clinical development and market success. Throughout his career, Christopher has worked closely with small-to-medium biotech and pharmaceutical oncology companies, developing novel technologies.

Kenny Carberry – Director, Clinical Development, Alira Health

Kenny Carberry

Kenny leads business development efforts and initiatives for early-stage healthcare companies in Alira Health. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

Related news

Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
Multimedia June 21, 2022
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
Genomic Testing Market Access MedTech
Publications May 27, 2022
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
CDMO MedTech Robotcs
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.